Effects of LPG and Ventilation Interventions on Reducing HAP and Improving Cardiopulmonary Health
Launched by HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY · Jun 2, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking into how using liquefied petroleum gas (LPG) for cooking and improving kitchen ventilation can help reduce harmful air pollution in homes and improve heart and lung health. The study will test four different groups: one group will continue using solid fuels without any ventilation, another will switch to LPG without ventilation, a third will keep using solid fuels but with better ventilation, and the fourth group will use both LPG and improved ventilation. The goal is to see if either method alone is effective, or if combining the two gives even better results. They will also look into how affordable and sustainable these changes are for households.
To participate, you must primarily use solid fuels like coal or wood for cooking and live in a home where ventilation can be installed. You should be between 18 and 74 years old and cook frequently. You will be randomly assigned to one of the four groups and provided with the necessary materials for your group. It's important to note that people with serious health issues, pregnant women, and smokers are not eligible to join. This study is not yet recruiting participants, but it aims to better understand how to improve indoor air quality and health in households.
Gender
ALL
Eligibility criteria
- • 1. Inclusion Criteria Primary Participants:
- • Primary use of solid fuels (coal, wood, charcoal, or crop residues) for cooking;
- • Kitchen is suitable for installing ventilation facilities;
- • The main cook in the household (cooking frequency ≥5 times/week);
- • Aged between 18 and 74 years;
- • Local permanent residents with no plans for long-term travel or relocation within one year.
- • Secondary Participants
- • ● Elderly individuals aged 65-74 who lived with the included primary participants.
- 2. Exclusion Criteria:
- • Clinical diagnosis of major chronic diseases such as severe respiratory diseases, cardiovascular diseases, malignant tumors, or end-stage renal disease;
- • Pregnant or breastfeeding women;
- • Current smokers or individuals with self-reported exposure to productive dust or other occupational hazards;
- • Individuals who are unable to fully understand the study process or clearly express their own complaints, such as those with psychiatric disorders or severe neuroses, or who cannot cooperate with the study for other reasons.
About Huazhong University Of Science And Technology
Huazhong University of Science and Technology (HUST) is a prestigious research university located in Wuhan, China, renowned for its commitment to advancing scientific knowledge and innovation in various fields, including medicine and healthcare. With a strong emphasis on interdisciplinary collaboration, HUST engages in cutting-edge clinical research aimed at improving patient outcomes and driving advancements in medical science. The university's clinical trial initiatives are supported by state-of-the-art facilities and a team of experienced researchers, making it a key player in the development of novel therapies and treatment strategies in the healthcare sector.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Kuai Yu
Principal Investigator
Huazhong University of Science and Technology
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported